COVID-19: Beyond Tomorrow
Darren Walker, JD
free access
has multimedia
has audio
JAMA. 2020;324(6):541-542. doi:10.1001/jama.2020.12904
In this Viewpoint the president of the Ford Foundation calls on philanthropic and other wealthy organizations to make creative and generous grants to less well-endowed counterpart institutions and communities to redress the racial and socioeconomic disparities exposed by the COVID-19 pandemic and continued killings of Black Americans.
-
Video:
COVID-19 and Health Justice
Eva Petkova, PhD; Elliott M. Antman, MD; Andrea B. Troxel, ScD
free access
JAMA. 2020;324(6):543-545. doi:10.1001/jama.2020.13042
This Viewpoint proposes principles and processes to allow pooling of individual patient data from clinical trials given decelerating participant recruitment at sites where the COVID-19 surge has been controlled and new cases are diminishing.
-
Editorial
Randomized Clinical Trials and COVID-19: Managing Expectations
Howard Bauchner, MD; Phil B. Fontanarosa, MD, MBA
JAMA
Grace M. Lee, MD, MPH; Beth P. Bell, MD, MPH; José R. Romero, MD
free access
JAMA. 2020;324(6):546-547. doi:10.1001/jama.2020.13167
This Viewpoint discusses the role of the Advisory Committee on Immunization Practices, a federal advisory committee that makes vaccine-related recommendations to the CDC and DHHS, in guiding the development and deployment of COVID-19 vaccines.
Petra Khoury, PharmD; Eid Azar, MD; Eveline Hitti, MD, MBA
free access
JAMA. 2020;324(6):548-549. doi:10.1001/jama.2020.12695
This Viewpoint describes the unique challenges faced by Lebanon, a small densely populated country with a fragmented health care system, in its response to the emerging COVID-19 pandemic, and it summarizes organizational, testing, and communications policies the nation has implemented that might be useful to other resource-limited countries and settings.
Daniel S. Budnitz, MD, MPH; Maribeth C. Lovegrove, MPH; Robert J. Geller, MD
JAMA. 2020;324(6):550-551. doi:10.1001/jama.2020.2152
This Viewpoint discusses the success of US legislation to help prevent medication overdoses in children and suggests strategies to continue to reduce these overdoses, including changes to child-resistant packaging.
John D. McGreevey III, MD; C. William Hanson III, MD; Ross Koppel, PhD
JAMA. 2020;324(6):552-553. doi:10.1001/jama.2020.2724
This Viewpoint discusses evidence supporting use of conversational agents in health care鈥攁rtificial intelligence (AI) programs that interpret users鈥 questions or concerns and respond with answers鈥攁nd proposes 12 domains (eg, safety, transparency, security) that clinicians and health care organizations should evaluate before using them for patient care.
Matcheri S. Keshavan, MD; Bruce H. Price, MD; Joseph B. Martin, MD, PhD
has audio
JAMA. 2020;324(6):554-555. doi:10.1001/jama.2020.0062
This Viewpoint reviews the historical convergence and then divergence of psychiatry and neurology as clinical disciplines and calls for a transformation of graduate and postgraduate education to integrate the two and span intersections of the humanities, philosophy, and science.
-
Conversations with Dr Bauchner:
The Convergence of Neurology and Psychiatry